Pharmaceuticals

Dupixent Proven Effective in Treating Chronic Obstructive Pulmonary Disease and Asthma

bexib
By bexib 0 Min Read

Results from the Phase 3 BOREAS and NOTUS trials showed that Dupixent reduced moderate to severe COPD exacerbations by 31% over 52 weeks.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article 2:00PM Water Cooler 8/26/2024 | naked capitalism
Next Article Lifetime Show Spotlights Military Veterans Finding New Careers at U.S. Steel
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Wallet Pass is a mobile marketing channel
Retail & E-commerce
Azzaro Group’s exciting new travel offering for 2025 combines the cultural hub of Cape Town with the unspoiled nature of the Okavango Delta
Hospitality & Tourism
Remaking history: Sarah Mather and Aquascope
Manufacturing
Christmas has arrived at Orelle – Luxury Hospitality Magazine
Hospitality & Tourism